Toxoplasma gondii is an intracellular parasite that causes disseminated infections in fetuses and immunocompromised individuals. Although gene regulation is important for parasite differentiation and pathogenesis, little is known about protein organization in the nucleus. Here we show that the fucose-binding Aleuria aurantia lectin (AAL) binds to numerous punctate structures in the nuclei of tachyzoites, bradyzoites, and sporozoites but not oocysts. AAL also binds to Hammondia and Neospora nuclei but not to more distantly related apicomplexans. Analyses of the AAL-enriched fraction indicate that AAL binds O-linked fucose added to Ser/Thr residues present in or adjacent to Ser-rich domains (SRDs). Sixty-nine Ser-rich proteins were reproducibly enriched with AAL, including nucleoporins, mRNA-processing enzymes, and cell-signaling proteins. Two endogenous SRDs-containing proteins and an SRD-YFP fusion localize with AAL to the nuclear membrane. Superresolution microscopy showed that the majority of the AAL signal localizes in proximity to nuclear pore complexes. Host cells modify secreted proteins with O-fucose; here we describe the O-fucosylation pathway in the nucleocytosol of a eukaryote. Furthermore, these results suggest O-fucosylation is a mechanism by which proteins involved in gene expression accumulate near the NPC.
T he apicomplexan parasite Toxoplasma gondii causes disseminated infections in humans, and these infections can lead to severe damage in immunocompromised individuals and fetuses (1, 2) . There is no human vaccine against T. gondii, and recently the price of pyrimethamine, the drug used to treat toxoplasmosis in the United States, has increased more than 50-fold (2) .
T. gondii has a complex life cycle, and the parasite's ability to differentiate through its life stages in response to stresses and environmental conditions is fundamental for its pathogenicity and transmission (3) . Transcriptome analyses have revealed that a large percentage of mRNAs show life stage-specific expression (4) and/or cell cycle regulation (5) . Recent studies have increased our understanding of gene expression in T. gondii by identifying the AP2 family of transcription factors (6) (7) (8) and by describing posttranslational modifications (PTMs) of histones and some of the enzymes responsible for them (9) (10) (11) . However, little is known about protein organization at the nuclear periphery, a subnuclear compartment that plays a critical role in transcriptional regulation in many eukaryotes. In particular, the gene-gating model (12) suggests that the nuclear pore complex (NPC) has a role in transcriptional regulation and chromatin organization as well as in protein and mRNA transport (13, 14) .
In T. gondii chromodomain protein 1 localizes with heterochromatin at the nuclear periphery (15) , and centromeres sequester to an apical nuclear region (16) . Although the nuclear localization signal (NLS) and importin-α system are present, key nuclear import and export molecules are not easily identified (17) (18) (19) . Furthermore, the NPC composition is divergent, so that only nucleoporins containing phenylalanine-glycine (FG) repeats (FG-Nups) and a putative Nup54 can be predicted by primary sequence homology (20) .
Here we report the discovery of numerous assemblies of O-fucosylated proteins that associate with the nuclear membrane near the NPCs. These results improve our understanding of the architecture of the T. gondii nuclear periphery and highlight O-fucosylation as a PTM involved in assemblies associated with the NPC.
Results
The Fucose-Binding Aleuria aurantia Lectin Labels the Nuclei of T. gondii in a Stage-Specific, Species-Specific, but Cell Cycle-Independent Manner.
Fucose is a common monosaccharide in many eukaryote and prokaryote glycoconjugates (21) . Because only one fucose-containing glycoconjugate, a pentasaccharide on S-phase kinase-associated protein 1 (Skp1) (22) , was known in T. gondii, we used Aleuria aurantia lectin (AAL), a lectin that binds to terminal fucose, to search for fucosylated glycans in its various life stages (Fig. 1A) . Unexpectedly, AAL strongly labels the nuclei of tachyzoites, bradyzoites, and sporozoites but fails to bind to the nuclei of oocysts (Fig. 1B) . Binding of anti-centrin antibodies to centrosomes shows that oocyst walls are permeabilized (23) . Transient expression of GAP40-YFP, which highlights the inner membrane complex (24) , shows that AAL binds to T. gondii nuclei throughout the tachyzoite cell cycle (Fig. S1) .
The apicomplexan phylogenetic tree based on housekeeping genes is cartooned in Fig. 1C . AAL binds to nuclei of T. gondii, Hammondia hammondi, and Neospora caninum, which are
Significance
We describe here the discovery that assemblies of O-fucosylated proteins localize to the nuclear membrane of Toxoplasma gondii, particularly in proximity to the nuclear pore complexes (NPCs). O-fucose is added to Ser and Thr residues found in some of the Phe-Gly (FG) domain-containing proteins that characterize the NPC channel as well as in Ser-rich sequences in many proteins predicted to have roles in transcription, mRNA processing, and cell signaling. O-fucosylation of nucleocytosolic proteins has not been described previously in any eukaryote and appears to be unique to T. gondii and closely related apicomplexans.
closely related species, but not to the nuclei of the more distantly related Sarcocystis neurona, Eimeria tenella, or Plasmodium falciparum (Fig. 1D) . Although AAL labels numerous loci within the nucleus of T. gondii, the lectin labels only one or two spots in the perinuclear region of Cryptosporidium parvum sporozoites. These results show that strong labeling of nuclei by AAL is not a common property of apicomplexans but instead appears to have developed after the divergence of T. gondii and S. neurona.
AAL binding to extracellular tachyzoites can be inhibited by preincubation with methyl-α-fucopyranoside (αMeFuc), as shown by flow cytometry and lectin blotting ( Fig. 2 A and B) , indicating the specificity of the carbohydrate-lectin interaction. Proteases and β-elimination treatments were also effective in blocking AAL binding to cell lysate, whereas peptide-N-glycosidase F (PNGase F) had no effect ( Fig. 2 B and C and Fig. S2C ), indicating that AAL binds to O-glycosylated proteins in T. gondii. In contrast, AAL binds to the N-glycans in the secretory pathway of human foreskin fibroblasts (HFFs), as shown by loss of binding on lectin blots only upon PNGase F treatment and by colocalization by immunofluorescence analysis with RCA120, a galactose-binding lectin ( Fig. S2 A and B) .
T. gondii Nuclear Fucosylation Is Dependent on the de Novo GDPFucose Biosynthetic Pathway. Because T. gondii and other apicomplexans have no salvage pathway for fucose (25, 26) , GDPfucose is synthesized from GDP-mannose in a three-step process catalyzed by GDP-mannose dehydratase (GMD, TGGT1_238940) and GDP-fucose synthase (Fig. S2D) (21) . Expression of Cas9 and a guide RNA (gRNA) targeting the first exon of the T. gondii gmd gene results in the loss of AAL binding to tachyzoite nuclei at 48 h post electroporation (Fig. 2D) . Immunostaining against inner membrane complex protein 3 (IMC3) indicates that the subpopulation of AAL-negative cells still maintains the correct cell morphology (27) . No loss of AAL binding was observed when cells were electroporated with Cas9 but without gRNA. So far we have been unable to isolate the gmd-depleted cells by cloning by limiting dilution with or without a selection agent (28) , suggesting either that gmd is essential or that its deletion causes a strong growth phenotype in T. gondii tachyzoites.
The only characterized downstream user of GDP-fucose (GDPFuc) in T. gondii is the Skp1 glycosylation pathway. T. gondii is one of a few organisms that add a pentasaccharide containing GlcNAc, Gal, and fucose to a hydroxyl-proline on Skp1, a E3 ubiquitin ligase adaptor (22, 29) . Knockout of Skp1 proline hydroxylase (phyA), GlcNAc transferase (gnt1), and bifunctional galactose and fucose transferase (pgtA) did not affect AAL binding (Fig. S3 ), indicating that biosynthesis of the AAL-positive glycan is independent of the Skp1 glycosylation pathway. and N. caninum) but not to more distantly related apicomplexans (S. neurona, E. tenella, and P. falciparum). Binding to sporozoites is shown for all species, with the exception of P. falciparum for which a trophozoite is shown. IMC3 marks the inner membrane complex, centrin marks the centrosome, and epichromatin marks the nuclear periphery. Griffonia simplicifolia lectin II (GSLII) labels the short P. falciparum N-glycans. All images were taken by deconvolution fluorescence microscopy. confirmed by either prompt neutral loss of at least one dHex, as indicated by the presence of peaks in the MS that correspond to different glycoforms detected at the same retention time, and/or by peaks in the MS/MS spectra that can be confidently assigned to peptide fragments containing dHex (Dataset S1). No sugars other than dHex were observed, indicating that AAL binds to O-fucose (O-Fuc). In a few cases, the same peptide was observed modified with a dHex and, at a later retention time, in its unglycosylated form, suggesting that the addition of O-Fuc may be a probabilistic event, i.e., that distinct pools of modified and unmodified protein may be present at that site (Dataset S1). The amino acid modified with O-Fuc could not be determined for most glycopeptides because of the labile nature of the O-Fuc and the low complexity of the amino acid sequence of most of the modified peptides (Fig. S4A) . Also, we cannot exclude the possibility of heterogeneity in the glycosylation sites. Combining high-energy collision dissociation (HCD) and electron-transfer dissociation (ETD) MS/MS data, we often were able to narrow the modification sites to two to six likely Ser/Thr residues ( Fig. S4B and Dataset S1). Furthermore, we were able to specify the modification site for one glycopeptide, T610 on TGGT1_203780 (Fig. 3B) , a putative FG-Nup and one of the most abundant proteins identified in the AAL-enriched fraction (Dataset S2). GC-MS monosaccharide composition analysis of the sugars released by reductive β-elimination identified fucose as the only dHex present in the AAL-enriched fraction ( Fig. S4 C and D) .
AAL Binds to
AAL Recognizes Proteins Involved in Gene Regulation. In most cases, O-Fuc is added to low-complexity Ser-rich domains (SRDs) or to sequences adjacent to these domains ( Fig. 4 A and F), and peptides with long SRDs are likely to have more than one dHex ( Fig. 3A and Dataset S1). We define SRDs as sequences with five or more Ser residues in tandem. More than 70% of the peptides identified in this study came from proteins that had one or more SRDs and/or contained more than 10% Ser (Fig. 3A, Fig. S5 A and B, and Dataset S2). Consistent with this observation, a higher number of proteins with Ser-15-mer are found in the apicomplexans that show nuclear AAL binding than in those that do not ( Fig. 1D and Fig. S5C ). Comparison of data from five biological repeats resulted in a set of 69 Ser-rich proteins reproducibly pulled down by AAL and/or for which we observed glycopeptides. We identified glycopeptides for 33 of the 69 AALenriched proteins (Table 1 and Dataset S2), and it is likely that numerous O-fucosylated peptides on long SRDs were not detected because of the paucity of flanking trypsin cleavage sites (Fig. 4A) . In contrast, proteins that were present in AAL-enriched pull-downs but that are likely contaminants because of their high abundance (e.g., ribosomal proteins, cytoskeletal components, chaperones, and so forth) do not contain SRDs and have an average Ser content of 6%. A control set comprising T. gondii proteins associated with nuclear and cytoplasmic Gene Ontology (GO) terms was shown to have an average Ser content of 9%, compared with the 15% Ser present in the O-fucosylated proteins or the SRD set (Fig. S5B ). About 40% of the 69 proteins with one or more SRDs contain a canonical NLS (cNLS), as identified by cNLS mapping (Table 1 , Fig. S5A , and Dataset S2) (30) . Analysis of PTMs showed that the majority of AAL-enriched proteins exhibit some degree of phosphorylation, but none is modified by ubiquitin. This result is in agreement with the datasets in refs. 31 and 32. AAL enriches five of seven predicted T. gondii nucleoporins (four FG-Nups and a Nup54 ortholog), each with one or more SRDs (Table 1 and Dataset S2). Also present in the AAL-enriched fraction are proteins predicted to be involved in mRNA processing, protein-protein interactions, ubiquitination, and enzymes that catalyze the addition/removal of phosphate groups from proteins and polyphosphate phosphatidylinositol (33, 34) . Transcription regulators and proteins with nucleotide-binding and chromosome-binding domains are also present (Table 1 and Dataset S2). Numerous hypothetical proteins are found, and these often are conserved in T. gondii, H. hammondi, and N. caninum but are absent in the apicomplexans that do not bind AAL (Fig. 1) .
O-Fucosylation Directs Glycoproteins to AAL-Labeled Assemblies
Associated with the Nuclear Membrane in Close Proximity to the NPC. Two AAL-enriched proteins were chosen for further studies: a putative Gly-Pro-Asn-loop GTPase (hereafter "GPN") and the transcriptional activator SWI/SNF2 (hereafter "SNF2"). GPN has a long N-terminal SRD but lacks an NLS (Fig. 4A) . The protein was tagged with 3×MYC at its C terminus (Fig. S6A ) and shown to be concentrated, like AAL, at the nuclear periphery but also was present in the cytosol, where no AAL labeling is observed (Fig. 4B) . The tagged protein was also enriched by AAL (Fig. 4C) . Addition of O-Fuc as a probabilistic event might explain why fucosylated GPN is present in the nucleus but unmodified GPN remains in the cytosol. The SRD from GPN was fused to the N terminus of YFP (SRD-YFP) and expressed in tachyzoites (Fig. S6B) . SRD-YFP localizes to the nucleus and to a lesser extent to the cytosol (Fig.  4D) . Both SRD-YFP and AAL are excluded from the nucleolus, as shown by costaining with anti-fibrillarin antibodies (Fig. S7 A  and B) . A band corresponding to the observed molecular weight of SRD-YFP was labeled by AAL on Western blots, and AAL reactivity was eliminated upon β-elimination (Fig. 4E) , indicating that SRD-YFP is modified with O-Fuc. In contrast, when the NLS from TgGNC5 (17) was added to the N terminus of YFP, it targeted the fluorescent protein to the nucleoplasm, including the nucleolus (Fig. 4D and Fig. S7A ). Western blots showed that NLS-YFP, despite its relative abundance as compared with SRD-YFP, does not bind AAL, indicating that it is not O-fucosylated (Fig. 4E) .
SNF2 has an SRD at amino acids 1871-1935 (Fig. 4F ) and three predicted NLS (amino acids 1005-1016, 2402-2410, and 2507-2517). SNF2, which was endogenously tagged with a 3×HA 2+ . Ions b13+ dHex and y6+dHex were observed, indicating that T610 (bold underlined) is the modified residue. Ions plus dHex are marked by a pink asterisk.
tag, localizes to the nucleus with AAL (Fig. 4G) . AAL pull-down confirmed that SNF2 is O-fucosylated (Fig. 4H) .
Superresolution microscopy shows that AAL binds to punctate structures that are adjacent to epichromatin (35) , a conformational epitope of DNA in complex with histones H2A and H2B that marks the nuclear periphery (Fig. 5C ). AAL binding is also found in proximity to euchromatin (Fig. S7C) , as defined by antibodies against two histone modifications associated with active transcription, H3K9Ac and H3K4Me3 (9) . Last, two predicted FG-NupsNup68, which is enriched by AAL, and Nup67, which is not-were expressed with a C-terminal YFP under their endogenous promoters ( Fig. S6 C and D) . Both fusion proteins partially colocalize with AAL at the nuclear membrane ( Fig. 5 A and B) , and in both cases, a subset of the AAL-labeled assemblies partially overlaps with the NPCs (see Insets in Fig. 5 A and B) . The glycopeptides observed in Nup68 and other two FG-Nups (TGGT1_203780 and TGGT1_313430) indicate that O-Fuc modifies the FG repeats region (Dataset S1).
Discussion
Almost all eukaryotes present a glycosylation pathway dedicated to the modification of cytosolic and nuclear proteins in which N-acetylglucosamine is transferred to Ser/Thr in disordered domains by O-GlcNAc transferase (OGT) (36) . Yeast, one of the few organisms lacking an OGT, recently has been shown to use O-mannose (O-Man) instead of O-GlcNAc to modify its nucleocytosolic proteins (37) . In contrast, T. gondii has three cytosolic glycosylation pathways: an OGT (38), the hydroxylase and glycosyltransferases (GTs) that modify Skp1 with a pentasaccharide (22) , and the nucleocytosolic O-fucosylation system described here. In the host and presumably in the parasite, the donor for the OGT reaction, UDP-GlcNAc, is sensitive to the metabolic state of the cell, and modification by O-GlcNAc affects protein activity (36) . Similarly, glycosylation of Skp1 is required for normal growth of tachyzoites in culture, and proline hydroxylation on Skp1 is sensitive to the redox status of T. gondii (22, 29) . In contrast, this study suggests that the addition of O-Fuc targets T. gondii proteins to assemblies closely associated with the nuclear membrane and that targeting of endogenous and exogenous proteins to the AAL-labeled assembly may occur in the absence of an NLS. SRD-YFP and two endogenous proteins, one containing a predicted NLS, are modified with O-Fuc and localize to the nuclear periphery, whereas the addition of an NLS to either Cas9 or YFP targets proteins to the nucleoplasm, including the nucleolus. Whether the addition of O-Fuc affects the activity of T. gondii proteins or protein-protein interactions was not determined.
Although O-fucosylation of Ser/Thr residues in secreted proteins of eukaryotic cells has been described previously, here we identify this modification on nuclear proteins. AAL staining suggests this pathway is conserved only in T. gondii, H. hammondi, and N. caninum. Both human fibroblasts (Fig. S2B) and bovine turbinate cells (Fig. 1D, S . neurona) did not show nuclear staining by AAL. Further studies should be performed in different taxonomic groups, but the limited data so far suggest that nuclear O-fucosylation may be restricted to these three species. Recognizing the limitations we have encountered thus far in defining the modification site(s) precisely, it appears that the unidentified T. gondii O-fucosyltransferase (OFucT) differs from host protein O-fucosyltransferases (POFUT1 and POFUT2) in its location and acceptor specificity. First, POFUTs are glycosyltransferases resident in the endoplasmic reticulum (ER) (21), whereas we predict that the T. gondii OFucT is either cytosolic or nuclear. Second, the host enzymes transfer O-Fuc to epidermal growth factor-like (POFUT1) or thrombospondin type I (POFUT2) repeats, both of which are characterized by conserved disulfide bonds (39, 40) , whereas disulfides do not form in cytosolic and nuclear proteins.
Our working model of protein O-fucosylation in T. gondii is shown in Fig. 5D . AAL enrichment and the identified glycopeptides suggest that for the most part the acceptors of the putative OFucT are SRDs or proteins containing such domains. However, it seems likely that not all nucleocytosolic proteins with SRDs were identified in the AAL enrichment. In our model, we speculate that an as-yet-unidentified fucose-binding lectin would recognize O-fucosylated proteins and participate in their accumulation in assemblies closely associated with the nuclear membrane. This idea would be similar to the host cell secretory pathway in which lectins bind glucosylated and mannosylated N-glycans (41) . Many hypothetical proteins, with no homology to any known conserved domains and specific to T. gondii, have been identified in the AAL pull-downs, and they may be important in forming the assemblies, i.e., the hypothesized fucose-binding lectin. The AAL-labeled assembly is also likely to contain proteins that are not O-fucosylated; in our model, these proteins would associate via protein-protein interactions. Proteinprotein interactions, disrupted during lysis, reform during lectin enrichment, and we therefore cannot exclude the possibility that some of the proteins isolated in the pull-down that were categorized as contaminants are actually nonfucosylated members of the assemblies. Isolation of the intact assemblies will be required to discriminate between nonfucosylated proteins that are members of the assemblies and true contaminants. This distinction might be complicated further by the possibility that the protein composition of the assembly is itself heterogeneous. Furthermore, we observed the addition of O-Fuc to be a probabilistic event for ∼20% of the identified glycopeptides. According to our model, the fucosylated form of the protein might be present in the AAL-labeled assembly, and the nonfucosylated form might diffuse into the nucleus if an NLS is present or remain in the cytosol if an NLS is absent, as suggested by the localization of GPN-3×MYC (Fig. 4D) . Whether addition of fucose as a probabilistic event is due to the OFucT mechanism and/or kinetics or is observed because nuclear O-Fuc, like O-GlcNAc, is a reversible modification cannot be clearly stated at this point. No putative O-fucosidase could be identified so far in T. gondii.
Multiple pieces of evidence point to the potential importance of the AAL-labeled assemblies in the nucleus of T. gondii. First, proteins in AAL pull-downs include numerous putative nucleoporins, mRNA processing enzymes, transcription regulators, and signaling proteins. Second, disruption of GDP-Fuc biosynthesis, which eliminates the binding of AAL to nuclei, appears to affect growth severely, as suggested by our inability to clone the AALnegative cells. The absence of AAL binding to oocyst nuclei suggests that these proteins are either absent or not glycosylated in these life stages, because electron microscopy showed that the nuclear membrane of sporulating T. gondii remains intact (42) . Last, five of seven predicted nucleoporins are present in the AAL enrichments, and tagged versions of Nup68 and Nup67 partially colocalize with AAL-labeled assemblies. Furthermore, MS showed that O-Fuc is found on three FG-Nups: Nup68, TGGT1_203780 [the second most abundant protein in the pulldown (Dataset S2)], and TGGT1_313430 [the T. gondii ortholog of yeast Nup98/96 (43)]. In all three instances, the sugar modifies the FG repeats region. FG regions are the disordered sequences that characterize the NPC channel and interact with karyopherins to mediate nuclear transport (19) . In higher eukaryotes and yeast, FG regions are highly decorated with O-GlcNAc and O-Man, respectively, and evidence suggests that this PTM could affect cargo selectivity (36, 37) .
O-fucosylation thus appears to be a mechanism by which T. gondii proteins involved in gene expression and mRNA processing (gating hypothesis) are gathered at the nuclear membrane, often in close proximity to the NPCs (14) , and components of the NPC itself are O-fucosylated.
Methods
Parasite Cell Culture and Manipulation. T. gondii type I RH tachyzoites culture, manipulation, and in vitro differentiation to bradyzoites were performed as previously described (7, 44) . The RH Δku80 (44) transgenic cell line has been described previously. RH Δku80 ΔphyA, Δgnt1, and ΔpgtA (22) were kind gifts from Christopher West, University of Georgia, Athens, GA and Ira Blader, SUNY at Buffalo School of Medicine, Buffalo, NY. RH SNF2-3xHA was a kind gift from William Sullivan, Jr, Indiana University School of Medicine, Indianapolis. The generation of transgenic cells expressing GPN-3xMYC, SRD-YFP, NLS-YFP, Nup68-YFP, and Nup67-YFP is described in SI Methods. All animal work was approved by the Institutional Animal Care and Use Committee at Boston University. C. parvum (Iowa strain) oocysts were purchased from Bunch Grass Farm. S. neurona SN3 was a kind gift from Michael Grigg, NIH, Bethesda, and P. falciparum was a kind gift from Jeffrey Dvorin, Harvard Medical School, Boston. N. caninum Nc-1 and H. hammondi were kind gifts of Jon Boyle, University of Pittsburgh, Pittsburgh. For oocyst excystation and fixation protocols, see SI Methods.
DNA Manipulation. All primers used in this study are listed in Table S1 . Cloning strategies and plasmids used are described in SI Methods.
Immunofluorescence Microscopy. Fixation, permeabilization, blocking, and labeling conditions are described in SI Methods. Deconvolution microscopy was performed on a Olympus XI70 inverted microscope and DeltaVision SoftWoRx as previously described (45) . Superresolution microscopy was An as yet unidentified OFucT transfers fucose (red triangle) to Ser/Thr residues on SRDcontaining proteins. O-fucosylated proteins then are shuttled to the nuclear periphery where they associate in assemblies, via protein-protein interactions and, possibly, an endogenous fucose-binding lectin (question mark). How the assembly of O-fucosylated proteins interacts with the NPC remains to be determined (question mark). According to the model, nonfucosylated proteins (asterisks) will stay in the cytosol or go to nucleus depending on the presence of an NLS. HP, hypothetical protein; K/P, kinase or phosphorylase domain; PPI, protein-protein interaction domain; RRM, RNA-recognition motif; TR, transcriptional regulator.
performed on an OMX-3D, V3 type (Applied Precision) or on an ELYRA (Zeiss) microscope. In both cases images were acquired with a 100×/1.4 oil immersion objective, 0.125-μm z sections at room temperature. For the OMX microscope, images were processed with OMX SoftWoRx software, and projections of 10× z stacks are shown. For the ELYRA microscope, images were processed for structured illumination (SIM) using ZEN software, and single optical sections were selected using Fiji (46) .
Lectin Pull-Down. Proteins were pulled down from total cell lysate by incubation with biotinylated AAL (Vector Labs) and Dynabeads MyOne Streptavidin T1 (Thermo Fisher) and were eluted by incubation with αMeFuc (Carbosynth). See SI Methods for details (47) .
MS. Proteins in the elution were reduced, alkylated, and digested with trypsin either in solution or in gel. Peptides and glycopeptides were analyzed by LC-MS/MS using a ChIP or an ultra-performance LC (UPLC) C18 column on a 6550-QTOF (Agilent Technologies), an LTQ-Orbitrap-XL-ETD, or a Q Exactive Plus Quadrupole hybrid Orbitrap (Thermo Scientific) MS system. The PTM search function within the analysis software PEAKS (Bioinformatic Solutions) (48) was used to produce a list of putative O-fucosylated peptides that was manually verified. Scaffold (Proteome Software) (49) was used to compare the five biological repeats, and further analyses were performed using RStudio. Monosaccharide composition analysis was performed on a Bruker Scion-SQ GC-MS (Bruker). See SI Methods for details.
